Last reviewed: June 8, 2026
Last updated: June 8, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Glucagon-like peptide-1 receptor agonist therapy has demonstrated weight loss outcomes averaging 15–22% of body weight in clinical trials, making it one of the most effective pharmacological interventions available today. Understanding when to begin GLP-1 treatment is personal—it depends on your health status, weight loss goals, and readiness to commit to medication. PlexusDx helps patients navigate this decision with personalized guidance and affordable access to compounded GLP-1 medications from licensed 503A pharmacies.
Understanding GLP-1 Therapy and How It Works
GLP-1 medications mimic a natural hormone your body produces after eating. This hormone tells your brain that you're full, slows stomach emptying, and reduces hunger signals throughout the day. Unlike older weight loss drugs, GLP-1 agonists work with your body's biology rather than forcing artificial appetite suppression. The result is sustainable weight loss that feels less like fighting your body and more like restoring balance.
Semaglutide, one of the most studied GLP-1 medications, has been shown in multiple randomized controlled trials to support weight loss when combined with lifestyle changes. PlexusDx compounds pharmaceutical-grade semaglutide through licensed 503A pharmacies, delivering the same active ingredient at a fraction of brand-name costs. Patients typically begin with a low dose and increase gradually over weeks or months, allowing their bodies to adapt while minimizing adjustment side effects.
Signs You May Be Ready to Start GLP-1 Treatment
You might be a candidate for GLP-1 therapy if you have struggled with weight loss despite diet and exercise efforts, carry excess weight that affects your health, or have been diagnosed with weight-related conditions like type 2 diabetes or high blood pressure. Medical guidelines suggest considering GLP-1 if your body mass index (BMI) is 30 or higher, or 27 or higher with weight-related health complications. However, readiness goes beyond numbers—you should feel mentally prepared to take a daily or weekly medication and commit to healthier eating habits.
Starting GLP-1 therapy works best when you have realistic expectations and genuine motivation to change. If you've tried multiple diets, weight loss programs, or medications without lasting results, or if your doctor has recommended pharmaceutical support, now may be the right time. PlexusDx accepts patients from all 50 states, with no insurance requirement and no membership fees, making access straightforward once you've decided to move forward.
Medical Criteria and Timing for Starting GLP-1
Most healthcare providers follow evidence-based guidelines when determining GLP-1 candidacy. You are typically eligible if you have a BMI of 30 or greater, regardless of other health factors, or a BMI of 27–29.9 plus at least one weight-related medical condition. Weight-related conditions include high blood pressure, type 2 diabetes, sleep apnea, heart disease, or metabolic syndrome. Your age, medications, and organ function also matter—GLP-1 is generally safe across age groups but requires careful review if you have a personal or family history of thyroid cancer or multiple endocrine neoplasia.
The timing question often hinges on motivation and lifestyle readiness rather than pure medical criteria. Starting during a period of stability—not during high stress, travel-heavy seasons, or major life changes—tends to improve adherence. PlexusDx pairs medication access with personalized guidance; the Precision Peptide Genetic Test, available as a $99 add-on after your first month, reveals how your unique genetics influence GLP-1 pathway responsiveness, helping you optimize your specific protocol.
Affordability and Access Through PlexusDx
Cost often determines whether patients actually begin GLP-1 therapy. Brand-name semaglutide (Ozempic, Wegovy) frequently costs $900–$1,500 monthly without insurance, pricing many people out of treatment entirely. PlexusDx compounded semaglutide injection starts at $149 per month, with no insurance needed, no membership fees, and full HSA/FSA eligibility. This pricing structure removes the financial barrier that has kept millions from accessing GLP-1 therapy.
PlexusDx serves patients across all 50 states and offers multiple formulations to match your lifestyle. Compounded semaglutide injection, oral semaglutide, compounded tirzepatide injection, oral tirzepatide, and combination protocols like GLP-Squared are all available. Your dose may need to go up as your body adapts and you progress toward your weight loss goal, but your price remains flat—no surprise cost jumps as your medication adjusts. This transparent pricing model, combined with licensed 503A pharmacy standards and no insurance requirements, makes personalized GLP-1 therapy genuinely accessible.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the minimum weight or BMI to qualify for GLP-1 therapy?
Medical guidelines suggest considering GLP-1 if your BMI is 30 or higher, or 27 or higher with weight-related health conditions such as high blood pressure, type 2 diabetes, or sleep apnea. However, individual circumstances vary, and PlexusDx evaluates each patient personally. Contact PlexusDx to discuss whether you are a candidate for compounded GLP-1 therapy.
How much weight can I expect to lose with GLP-1 therapy?
Clinical trials show average weight loss of 15–22% of body weight when GLP-1 is combined with lifestyle changes over 68 weeks. Individual results vary significantly based on genetics, adherence, diet, exercise, and starting weight. PlexusDx's Precision Peptide Genetic Test identifies how your unique genetic profile influences peptide-pathway responsiveness, helping predict your personal outcome potential.
How much does GLP-1 therapy cost through PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month, with no insurance required, no membership fees, and full HSA/FSA eligibility. Your dose may increase as treatment progresses, but your price stays flat. PlexusDx also offers oral semaglutide, tirzepatide injections, and combination protocols at different price points, all with transparent, dose-independent monthly rates.
Are compounded GLP-1 medications from PlexusDx safe?
Yes. PlexusDx sources all medications from licensed 503A compounding pharmacies, which follow FDA oversight and pharmaceutical-grade standards. Compounded semaglutide and tirzepatide contain the same active ingredients as brand-name versions but at significantly lower cost. As with any medication, side effects are possible and typically include nausea, constipation, or mild injection-site reactions; these usually diminish as your body adjusts.
What is the Precision Peptide Genetic Test, and how does it help?
The Precision Peptide Genetic Test ($99 add-on after month one) analyzes 14 pathways, 49 peptides, and 150+ genetic insights to reveal how your genetics influence GLP-1 and related hormone pathways. Key variants like GIPR rs1800437 and GLP1R rs6923761 predict individual treatment response, helping PlexusDx personalize your medication choice and dosing strategy for maximum effectiveness.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Help You Stop Drinking?
How Long After First Injection Does Semaglutide Work?